A record of what Jigar S. Patel said publicly, with the source. Not advice.
“Bullish on Dr. Lal Path Labs for the next one to two weeks, advising a buying range of ₹3,160–3,130 with a target of ₹3,460 and a stop loss at ₹2,985. The stock has established multiple bottoms near its 200-day EMA and exhibits bullish divergence on MACD, indicating a potential upside reversal.”
Jigar S. Patel’s track record (trackable calls only): 147 graded calls · 95% CI 13–25%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.
Entry zone: ₹3,130–₹3,160. The call starts at the first close that comes into it.
Target ₹3,460, stop ₹2,985, as stated.
Window: 14 days, the time frame the call states ("one to two weeks").
Neither the target ₹3,460 nor the stop ₹2,985 was reached on a close by the end of the window. Miss.
The grader’s working: R3 TRADE_SETUP: entered ₹3160 on 2025-11-20 (stated entry ₹3130–3160 zone, ZONE entry, filled); neither target nor stop reached by window end 2025-12-01. Window 14 days — rule H1: the quote states "one to two weeks".
How it played out
How this is worked out- Target or stop first
- Neither the target nor the stop was reached on a close by the end of the window.
- Time to target
- The target was not reached on a close inside the window.
- Worst close against it
- The closing price went as far as 3.42% against the call up to 1 Dec 2025, when the call was decided, measured from the entry price. Closing prices only; an intraday dip is never counted.
From the entry the grade used, on closing prices. This is a record of one past call and is not advice.